Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Agile regulations for advanced therapeutic products and clinical trials From Health Canada Current status: Closed This consultation ran from July 18, 2019 to September 30, 2019. The goal of this consultation was to seek feedback on what Health Canada should consider in developing…
Health and Biosciences: Targeted Regulatory Review – Regulatory Roadmap Latest updates – Health and bioscience review Regulatory Roadmap Program and policy initiatives and novel regulatory approaches Forward regulatory plans Published: June 2019 Last update: January 2021 The…
Regulatory innovation for health products: Information to Canadians – mobile strategy Overview Modernizing clinical trial regulations Enabling advanced therapeutic products Agile licensing for drugs Agile licensing for medical devices Information to Canadians - mobile strategy On…
Regulatory innovation for health products: Agile licensing for medical devices Overview Modernizing clinical trial regulations Enabling advanced therapeutic products Agile licensing for drugs Agile licensing for medical devices Information to Canadians - mobile strategy On this…
Regulatory innovation for health products: Agile licensing for drugs Overview Modernizing clinical trial regulations Enabling advanced therapeutic products Agile licensing for drugs Agile licensing for medical devices Information to Canadians - mobile strategy On this page Why we…
Regulatory innovation for health products: Enabling advanced therapeutic products Overview Modernizing clinical trial regulations Enabling advanced therapeutic products Agile licensing for drugs Agile licensing for medical devices Information to Canadians - mobile strategy On…
Regulatory innovation for health products: Modernizing clinical trial regulations Overview Modernizing clinical trial regulations Enabling advanced therapeutic products Agile licensing for drugs Agile licensing for medical devices Information to Canadians - mobile strategy On…
Strategies and Initiatives Health Canada develops and implements policies intended to maintain and improve the health of Canadians. Current key areas of concern include: promoting good health strengthening health care providing relevant health information Canadian Diabetes…
Notice: Prescription Drug List (PDL): Multiple Additions February 13, 2020 Our file number: 20-102134-993 The purpose of this Notice of Amendment is to notify about the additions of gemtuzumab ozogamacin, gilteritinib, icosapent ethyl, tafamidis, trifarotine and upadacitinib to…
Notice: Prescription Drug List (PDL): Multiple Additions Date: November 29, 2019 Our file number: 19-122114-257 The purpose of this Notice of Amendment is to notify about the additions of Bacillus Calmette-Guérin (BCG), edaravone, erdafitinib, plecanatide and talazoparib to the…
Early release: coverage and features are still expanding.
